<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Infectious folliculitis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Infectious folliculitis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Infectious folliculitis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeremy D Jackson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ted Rosen, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Abena O Ofori, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 04, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H604478843">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Folliculitis refers to inflammation of the superficial or deep portion of the hair follicle. The classic clinical findings of superficial folliculitis are folliculocentric, inflamed papules and/or pustules on hair-bearing skin  (
         <a class="graphic graphic_picture graphicRef103499 graphicRef62930 graphicRef103535" href="/z/d/graphic/103499.html" rel="external">
          picture 1A-C
         </a>
         ). Nodules are a feature of deep, follicular inflammation.
        </p>
        <p>
         Folliculitis may be infectious or, less frequently, noninfectious. Various bacteria, fungi, viruses, and parasites are causes of infectious folliculitis, with bacteria as the most common cause.
        </p>
        <p>
         A correct diagnosis of infectious folliculitis is essential for appropriate management. The patient history and physical examination, particularly the assessment of the distribution of folliculitis, help to narrow the differential diagnosis. Detection of the causative organism confirms the diagnosis and may help direct therapy. (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p>
         The etiologies, clinical manifestations, diagnosis, and management of infectious folliculitis will be reviewed here. Noninfectious causes of folliculitis are reviewed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1733.html" rel="external">
          "Approach to the patient with pustular skin lesions"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1734.html" rel="external">
          "Approach to the patient with a scalp disorder", section on 'Pustules'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4032.html" rel="external">
          "HIV-associated eosinophilic folliculitis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15685.html" rel="external">
          "Folliculitis decalvans"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/108935.html" rel="external">
          "Perforating dermatoses", section on 'Perforating folliculitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3586866458">
         <span class="h1">
          MAJOR SUBTYPES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major subtypes of infectious folliculitis include bacterial, fungal, viral, and parasitic folliculitis. The most commonly reported clinical variants of these subtypes are as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bacterial:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Staphylococcal folliculitis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pseudomonal folliculitis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gram-negative folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fungal:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Malassezia
         </em>
         (
         <em>
          Pityrosporum
         </em>
         ) folliculitis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dermatophytic folliculitis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Candida
         </em>
         (candidal) folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viral:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Herpetic folliculitis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Molluscum folliculitis (rare)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Parasitic:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Demodex
         </em>
         (demodectic) folliculitis
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12422132">
         <span class="h1">
          WHEN TO SUSPECT
         </span>
         <span class="headingEndMark">
          —
         </span>
         A diagnosis of infectious folliculitis should be considered in patients presenting with folliculocentric papules and pustules.
        </p>
        <p>
         The physical examination and patient history play important roles in narrowing the differential diagnosis. Assessments of the distribution of involvement, associated clinical findings, and risk factors for folliculitis are particularly helpful for identifying features that suggest specific types of infectious folliculitis:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Common distributions
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Scalp –
         <em>
          Staphylococcus aureus
         </em>
         folliculitis or dermatophytic folliculitis (tinea capitis)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Face –
         <em>
          S. aureus
         </em>
         ,
         <em>
          Demodex
         </em>
         , or gram-negative folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Beard –
         <em>
          S. aureus
         </em>
         folliculitis (sycosis barbae), dermatophytic folliculitis (tinea barbae),
         <em>
          Candida
         </em>
         folliculitis, or herpetic folliculitis (herpetic sycosis)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Trunk or extremities –
         <em>
          S. aureus
         </em>
         , pseudomonal,
         <em>
          Malassezia
         </em>
         , dermatophytic, or
         <em>
          Candida
         </em>
         folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated physical findings
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monomorphic, follicularly based papules, particularly on the posterior trunk –
         <em>
          Malassezia
         </em>
         folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Grouped or clustered lesions – Herpetic folliculitis (varicella zoster virus [VZV] or herpes simplex virus [HSV])
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Umbilicated papules – Molluscum folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Exposure to hot tubs or heated swimming pools – Pseudomonal folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prolonged oral antibiotic therapy – Gram-negative folliculitis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Immunosuppression – Increases suspicion for fungal, viral, or demodectic folliculitis
        </p>
        <p>
        </p>
        <p>
         The clinical assessment is also helpful for identifying patients with features supportive of other disorders. Examples of features that should prompt consideration of other disorders include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lesions that are not centered around follicles
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Keratotic, follicular papules as the primary finding (suggests a disorder of follicular keratinization [eg, keratosis pilaris, lichen spinulosus, phrynoderma])
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Absence of any clinical signs of inflammation, such as erythema, hyperpigmentation, or tenderness
        </p>
        <p>
        </p>
        <p>
         In addition, given the common presence of pustules in infectious folliculitis, an absence of pustules should raise suspicion for an alternative diagnosis but does not rule out infectious folliculitis.
        </p>
        <p>
         Examples of common disorders in the differential diagnosis of infectious folliculitis are reviewed below. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1293018169">
         <span class="h1">
          ETIOLOGY AND CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H604478849">
         <span class="h2">
          Bacterial folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial infection is the most common cause of infectious folliculitis. Common causes of bacterial folliculitis include
         <em>
          S. aureus
         </em>
         and gram-negative bacteria. (See
         <a class="local">
          'Staphylococcal folliculitis'
         </a>
         below and
         <a class="local">
          'Pseudomonal folliculitis'
         </a>
         below and
         <a class="local">
          'Other gram-negative folliculitis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1637671753">
         <span class="h3">
          Staphylococcal folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         –
         <em>
          S. aureus
         </em>
         , a gram-positive bacterium, is the most common cause of bacterial folliculitis. "Impetigo of Bockhart" and "Bockhart impetigo" are alternative terms for superficial staphylococcal folliculitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Both methicillin-sensitive
         <em>
          Staphylococcus aureus
         </em>
         (MSSA) and methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) can cause folliculitis. (See
         <a class="medical medical_review" href="/z/d/html/3157.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6065.html" rel="external">
          "Methicillin-resistant
          <i>
           Staphylococcus aureus
          </i>
          infections in children: Epidemiology and clinical spectrum"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Coagulase-negative staphylococci species (
         <em>
          Staphylococcus epidermidis
         </em>
         and
         <em>
          Staphylococcus capitis
         </em>
         ) have also been associated with bacterial folliculitis [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Staphylococcal folliculitis can occur in infants, children, or adults. Examples of factors that may increase risk include nasal carriage of
         <em>
          S. aureus
         </em>
         , hyperhidrosis, occlusion of hair follicles, and shaving [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         –
         <em>
         </em>
         The classic clinical findings in bacterial folliculitis are follicular pustules and inflamed, follicular papules  (
         <a class="graphic graphic_picture graphicRef103499 graphicRef103500 graphicRef62930 graphicRef50187" href="/z/d/graphic/103499.html" rel="external">
          picture 1A-B, 1D-E
         </a>
         ). Common sites include the scalp, face, upper trunk, buttocks, and legs, as well as the axillae in infants and children [
         <a href="#rid3">
          3,4
         </a>
         ]. Pruritus is common. Tender lesions may be present
         <em>
          .
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Folliculitis barbae (also known as sycosis barbae) is a bacterial folliculitis involving deep portions of the hair follicles in the beard areas of the face and ne
         <em>
          ck
         </em>
         .
         <em>
          S. aureus
         </em>
         is a frequent causative organism. Folliculitis barbae often presents with tender pustules within erythematous plaques involving multiple hair follicles  (
         <a class="graphic graphic_picture graphicRef129418" href="/z/d/graphic/129418.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid3">
          3,4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1060373459">
         <span class="h3">
          Pseudomonal folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         –
         <em>
          Pseudomonas aeruginosa
         </em>
         is a gram-negative bacterium and the cause of "hot tub folliculitis," a form of folliculitis attributed to contact with water contaminated with
         <em>
          Pseudomonas
         </em>
         as a result of inadequate chlorine, bromine, or pH levels in whirlpools, hot tubs, or swimming pools [
         <a href="#rid5">
          5
         </a>
         ]. Bathing with contaminated sponges or nylon towels and use of contaminated rubber gloves are additional potential modes of acquisition [
         <a href="#rid6">
          6-8
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7643.html" rel="external">
          "Pseudomonas aeruginosa skin and soft tissue infections", section on 'Hot tub-associated eruptions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – "Hot tub folliculitis" induced by
         <em>
          P. aeruginosa
         </em>
         presents with pruritic, inflamed, follicular macules, papules, or pustules  (
         <a class="graphic graphic_picture graphicRef98255 graphicRef98256" href="/z/d/graphic/98255.html" rel="external">
          picture 3A-B
         </a>
         ). The eruption appears 8 to 48 hours after exposure and primarily occurs on the trunk and buttocks in the distribution of the wet bathing suit or other areas exposed to contaminated water [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7643.html" rel="external">
          "Pseudomonas aeruginosa skin and soft tissue infections", section on 'Hot tub-associated eruptions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3913481965">
         <span class="h3">
          Other gram-negative folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         – Other organisms often responsible for gram-negative folliculitis include
         <em>
          Klebsiella
         </em>
         ,
         <em>
          Enterobacter
         </em>
         , and
         <em>
          Proteus
         </em>
         species. In addition,
         <em>
          Aeromonas hydrophila
         </em>
         , another gram-negative organism, has been linked to folliculitis after exposure to water [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Gram-negative folliculitis has been associated with long-term treatment with oral antibiotics (eg, tetracyclines) for acne vulgaris or rosacea but may also occur in the absence of this history [
         <a href="#rid10">
          10
         </a>
         ]. When gram-negative folliculitis occurs in association with long-term antibiotic therapy, it usually has an explosive onset. Male sex may be a risk factor; in one series, males accounted for 39 of 46 patients with gram-negative folliculitis [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/39.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Gram-negative folliculitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Patients usually present with erythematous papules and pustules on the face, most commonly in the perinasal region.
         <em>
          Proteus mirabilis
         </em>
         gram negative-folliculitis may also present with inflamed, painful, deep-seated nodules and pustules [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3055025611">
         <span class="h2">
          Fungal folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         After
         <em>
          S. aureus
         </em>
         , fungi are the most common causes of infectious folliculitis.
         <em>
          Malassezia
         </em>
         species, dermatophytes, and
         <em>
          Candida albicans
         </em>
         can cause fungal folliculitis.
        </p>
        <p class="headingAnchor" id="H814692712">
         <span class="h3">
          <i>
           Malassezia
          </i>
          (
          <i>
           Pityrosporum
          </i>
          ) folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         – Multiple species of
         <em>
          Malassezia
         </em>
         , lipophilic yeasts present in the normal cutaneous flora, cause folliculitis. The most common species are
         <em>
          Malassezia globosa
         </em>
         ,
         <em>
          Malassezia sympodialis
         </em>
         ,
         <em>
          Malassezia furfur
         </em>
         ,
         <em>
         </em>
         and
         <em>
          Malassezia restricta
         </em>
         [
         <a href="#rid11">
          11
         </a>
         ]
         <em>
          .
         </em>
         These fungi were previously classified under the genus
         <em>
          Pityrosporum
         </em>
         (
         <em>
          Pityrosporum orbiculare
         </em>
         ,
         <em>
          Pityrosporum ovale
         </em>
         , and
         <em>
          Pityrosporum pachydermatis
         </em>
         ), contributing to the alternative name "
         <em>
          Pityrosporum
         </em>
         folliculitis" [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         High sebum production and increased sweating are both predisposing factors for
         <em>
          Malassezia
         </em>
         folliculitis [
         <a href="#rid11">
          11
         </a>
         ]. In accordance with this,
         <em>
          Malassezia
         </em>
         folliculitis may be more likely to occur in hot, humid climates. In a review of 44 patients with
         <em>
          Malassezia
         </em>
         folliculitis in Japan, 75 percent reported onset during the summer months [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other potential predisposing factors include topical or oral antibiotic use, topical or oral corticosteroid treatment, and immunosuppression [
         <a href="#rid13">
          13-17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         <em>
         </em>
         –
         <em>
          Malassezia
         </em>
         folliculitis presents with pruritic, monomorphic, follicular papules or pustules on the chest, back, and/or shoulders  (
         <a class="graphic graphic_picture graphicRef86998 graphicRef86997" href="/z/d/graphic/86998.html" rel="external">
          picture 4A-B
         </a>
         ). Other potential sites of involvement include the face, neck, and extensor side of the arms. In patients with facial involvement, lesions typically occur on the forehead, chin, and sides of the face [
         <a href="#rid11">
          11,17
         </a>
         ]. The central face is usually spared.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2804792927">
         <span class="h3">
          Dermatophytic folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         –
         <em>
          Trichophyton
         </em>
         ,
         <em>
          Epidermophyton
         </em>
         ,
         <em>
         </em>
         and
         <em>
          Microsporum
         </em>
         species are the usual causes of dermatophytic folliculitis. Tinea capitis (dermatophytic infection of the scalp) and tinea barbae (dermatophytic infection of the beard or mustache areas) are classic forms of dermatophytic infection involving hair follicles. Tinea capitis is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/99983.html" rel="external">
          "Tinea capitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Majocchi's granuloma is a clinical subtype of dermatophytic folliculitis occurring on sites other than the scalp and beard. Majocchi's granuloma is characterized by deep, follicular and dermal involvement and is commonly caused by
         <em>
          Trichophyton rubrum
         </em>
         [
         <a href="#rid3">
          3
         </a>
         ]. Predisposing factors include shaving of the legs, topical corticosteroid use, and immunocompromised status [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – Tinea barbae and Majocchi's granuloma often manifest as follicular pustules surrounded by an erythematous plaque  (
         <a class="graphic graphic_picture graphicRef86999 graphicRef117243 graphicRef87000 graphicRef129800 graphicRef103535 graphicRef103536" href="/z/d/graphic/86999.html" rel="external">
          picture 1C, 1F-J
         </a>
         ). Hair loss in the affected site is common. Clinical features of tinea capitis are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/99983.html" rel="external">
          "Tinea capitis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The most common presentation of Majocchi's granuloma is a unilateral eruption on the lower extremity  (
         <a class="graphic graphic_picture graphicRef103535 graphicRef103536" href="/z/d/graphic/103535.html" rel="external">
          picture 1C, 1J
         </a>
         ). The upper extremities, specifically the forearm and dorsal hand, are additional common locations. Patients may have associated findings of tinea corporis, tinea cruris, or tinea pedis in other body areas.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1377121091">
         <span class="h3">
          Candidal folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         – Cutaneous
         <strong>
         </strong>
         <em>
          C. albicans
         </em>
         infection may cause fungal folliculitis.
         <em>
          Candida
         </em>
         folliculitis has occurred in association with candidemia in intravenous drug users but also occurs in healthy individuals [
         <a href="#rid3">
          3
         </a>
         ]. Immobility can produce an artificially moist, occlusive environment and lead to
         <em>
          Candida
         </em>
         folliculitis (eg, the occurrence of candidal folliculitis on the back of a nonambulatory, postoperative patient).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         –
         <em>
          Candida
         </em>
         folliculitis has been described as a widely distributed, pustular folliculitis as well as localized, inflammatory, papulopustular eruptions in the beard, mustache, scalp, or other hair-bearing areas, including the trunk  (
         <a class="graphic graphic_picture graphicRef129428 graphicRef129427" href="/z/d/graphic/129428.html" rel="external">
          picture 5A-B
         </a>
         ) [
         <a href="#rid3">
          3,19,20
         </a>
         ]. Beard involvement can mimic tinea barbae, manifesting as a fluctuant plaque on the face with follicular pustules and papules [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H428943235">
         <span class="h2">
          Viral folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viral folliculitis is most commonly associated with herpesvirus infections. Molluscum contagiosum virus (MCV) is a less common cause of viral folliculitis.
        </p>
        <p class="headingAnchor" id="H1159810731">
         <span class="h3">
          Herpetic folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         – Herpetic folliculitis is a rare manifestation of herpesvirus infections. It is most commonly associated with varicella zoster virus (VZV) infection but also can be attributed to herpes simplex virus (HSV) 1 or HSV-2. HSV is less likely than VZV to target the hair follicle [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Erythematous papules, pustules, vesicles, papulovesicles, and plaques are the most common presentations of herpetic folliculitis  (
         <a class="graphic graphic_picture graphicRef129425 graphicRef129426" href="/z/d/graphic/129425.html" rel="external">
          picture 6A-B
         </a>
         ) [
         <a href="#rid22">
          22,23
         </a>
         ]. These lesions are often grouped or clustered [
         <a href="#rid23">
          23
         </a>
         ]. HSV folliculitis in the beard area (herpetic sycosis) is reported most commonly in immunocompromised patients but may also occur in the absence of immunosuppression [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H411439453">
         <span class="h3">
          Molluscum folliculitis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         – MCV is a poxvirus that preferentially affects children and immunocompromised adults but also occurs in healthy adults. MCV is a rare cause of viral folliculitis [
         <a href="#rid26">
          26-28
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4033.html" rel="external">
          "Molluscum contagiosum"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – Inflamed papules and pustules appearing in conjunction with the characteristic umbilicated papules of molluscum contagiosum are typical findings in molluscum folliculitis. Molluscum folliculitis is distinct from the frequent occurrence of erythema and swelling of molluscum lesions prior to clinical resolution. (See
         <a class="medical medical_review" href="/z/d/html/4033.html" rel="external">
          "Molluscum contagiosum", section on 'Inflamed lesions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Noninflamed, pearly, and nonumbilicated papules have been reported as an alternative manifestation [
         <a href="#rid29">
          29
         </a>
         ]. Presentations resembling tinea barbae and pseudolymphoma have also occurred [
         <a href="#rid24">
          24-26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4007996198">
         <span class="h2">
          <i>
           Demodex
          </i>
          folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Demodex folliculorum
         </em>
         is a mite belonging to the class of arachnids and a proposed cause of facial folliculitis.
         <em>
          Demodex
         </em>
         mites are also proposed to contribute to the pathogenesis of papulopustular rosacea and chronic blepharitis [
         <a href="#rid30">
          30,31
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology and risk factors
         </strong>
         – The role of
         <em>
          D. folliculorum
         </em>
         in folliculitis is controversial because the mite is a common inhabitant of the pilosebaceous unit in normal skin. Up to 80 to 90 percent of humans may harbor the
         <em>
          Demodex
         </em>
         organism
         <em>
         </em>
         [
         <a href="#rid32">
          32
         </a>
         ]. Support for a pathogenic role in folliculitis and rosacea stems from improvement in these disorders with anti-
         <em>
          Demodex
         </em>
         therapies [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <em>
          Demodex
         </em>
         folliculitis is most frequently diagnosed in adults. However,
         <em>
          Demodex
         </em>
         folliculitis has also been implicated in facial pustules and papules in children [
         <a href="#rid33">
          33
         </a>
         ]. Immunosuppression, particularly related to HIV infection, may increase risk for cutaneous manifestations of
         <em>
          Demodex
         </em>
         infection [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         –
         <em>
          Demodex
         </em>
         folliculitis is usually characterized by rosacea-like, inflammatory papules and pustules on the face and neck  (
         <a class="graphic graphic_picture graphicRef128984" href="/z/d/graphic/128984.html" rel="external">
          picture 7
         </a>
         ) [
         <a href="#rid32">
          32
         </a>
         ]. In addition, nodulocystic and conglobate (abscess-like) presentations have occurred [
         <a href="#rid35">
          35
         </a>
         ].
         <em>
          Demodex
         </em>
         folliculitis is often first suspected when patients with a rosacea-like, papulopustular eruption fail to respond to antibiotic therapy for rosacea.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H604478868">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Folliculitis is usually suspected based upon the patient history and physical examination. Identification of the causative organism confirms the diagnosis:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bacterial folliculitis
         </strong>
         – Staphylococcal and pseudomonal folliculitis are usually diagnosed by means of the patient history and physical examination. Further work-up is primarily reserved for patients without findings that strongly suggest these diagnoses and treatment-resistant disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A Gram stain and culture of the contents of a pustule can confirm the presence of bacterial infection and identify the causative organism. (See
         <a class="medical medical_review" href="/z/d/html/2746.html" rel="external">
          "Approach to Gram stain and culture results in the microbiology laboratory"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Infrequently, a skin biopsy is necessary to differentiate bacterial folliculitis from other skin conditions. Histopathologic examination of bacterial folliculitis shows neutrophils infiltrating a hair follicle  (
         <a class="graphic graphic_picture graphicRef103501" href="/z/d/graphic/103501.html" rel="external">
          picture 8
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fungal folliculitis
         </strong>
         – Fungal folliculitis may be confirmed with a potassium hydroxide (KOH) preparation, fungal culture, or skin biopsies. A periodic acid-Schiff (PAS) or Gomori methenamine silver (GMS) stain may be performed to highlight fungal elements in skin biopsy specimens:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          <em>
           Malassezia
          </em>
         </strong>
         <strong>
          folliculitis
         </strong>
         – A KOH preparation is often sufficient to confirm a diagnosis of
         <em>
          Malassezia
         </em>
         folliculitis. Samples for the preparation can be obtained through superficial scraping of a pustule. The detection of budding spores and short, curved hyphae, similar to those seen in tinea versicolor  (
         <a class="graphic graphic_picture graphicRef58965" href="/z/d/graphic/58965.html" rel="external">
          picture 9
         </a>
         ), supports the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">
          "Office-based dermatologic diagnostic procedures", section on 'Potassium hydroxide preparation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         A skin biopsy may also detect fungal forms consistent with
         <em>
          Malassezia
         </em>
         and can be useful when suspicion for
         <em>
          Malassezia
         </em>
         folliculitis remains despite a negative KOH preparation  (
         <a class="graphic graphic_picture graphicRef103503" href="/z/d/graphic/103503.html" rel="external">
          picture 10
         </a>
         ). Clinical correlation is important becau
         <em>
          se Malassezia
         </em>
         can be seen in normal hair follicles.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Cultures for
         <em>
          Malassezia
         </em>
         are not routinely performed because
         <em>
          Malassezia
         </em>
         is difficult to culture without specialized media.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Dermatophytic folliculitis
         </strong>
         – Although a KOH preparation that detects septate hyphae consistent with dermatophyte infection confirms a diagnosis of dermatophytic folliculitis, negative tests are not uncommon and do not rule out the diagnosis. The ideal sample for a KOH preparation includes hairs plucked from the involved area and scrapings of associated scale. (See
         <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">
          "Office-based dermatologic diagnostic procedures", section on 'Potassium hydroxide preparation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         If a KOH preparation cannot be performed or is negative, alternative methods for diagnosis include skin biopsy and fungal culture. Skin biopsies are often preferred for Majocchi's granuloma, as the presence of dermatophytes is easily and relatively quickly confirmed on histopathology  (
         <a class="graphic graphic_picture graphicRef103502" href="/z/d/graphic/103502.html" rel="external">
          picture 11
         </a>
         ). However, for tinea barbae, the desire to avoid scarring on the face may favor performance of a fungal culture rather than skin biopsy. A disadvantage of fungal cultures is that results may not be available for a few weeks.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The approach to the diagnosis of tinea capitis is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/99983.html" rel="external">
          "Tinea capitis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          <em>
           Candida
          </em>
         </strong>
         <strong>
          folliculitis
         </strong>
         –
         <em>
          Candida
         </em>
         folliculitis may be diagnosed via a KOH preparation. The detection of yeast cells and pseudohyphae suggests
         <em>
          Candida
         </em>
         infection  (
         <a class="graphic graphic_picture graphicRef64872" href="/z/d/graphic/64872.html" rel="external">
          picture 12
         </a>
         ) [
         <a href="#rid21">
          21
         </a>
         ]. Fungal cultures and skin biopsies are generally reserved for confirming the diagnosis in cases in which the KOH preparation is negative or cannot be performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Viral folliculitis
         </strong>
         – Additional tests are indicated to confirm a diagnosis of herpetic folliculitis. In contrast, clinical examination is typically sufficient for the diagnosis of molluscum folliculitis:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Herpetic folliculitis
         </strong>
         – Testing of skin lesions should be performed to confirm varicella zoster virus (VZV) or herpes simplex virus (HSV) infection if a diagnosis of herpetic folliculitis is suspected [
         <a href="#rid23">
          23
         </a>
         ]. Options for testing include viral culture, polymerase chain reaction (PCR), or immunofluorescence testing. (See
         <a class="medical medical_review" href="/z/d/html/8329.html" rel="external">
          "Diagnosis of varicella-zoster virus infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Tests to confirm the diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         A skin biopsy is not usually necessary but may also detect findings consistent with herpetic folliculitis, such as intranuclear viral inclusions with multinucleated giant cells in and around the follicular epithelium.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Molluscum folliculitis
         </strong>
         – The presence of umbilicated papules in the region of folliculitis suggests molluscum folliculitis, and the physical examination is usually sufficient for diagnosis. A skin biopsy can be helpful when the diagnosis is unclear. Skin biopsies will reveal characteristic molluscum bodies (Henderson-Patterson bodies) in the follicular epithelium [
         <a href="#rid26">
          26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4033.html" rel="external">
          "Molluscum contagiosum", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Demodex folliculitis
         </strong>
         – A KOH preparation of a skin scraping from an involved area is typically used to detect
         <em>
          Demodex
         </em>
         mites  (
         <a class="graphic graphic_picture graphicRef128983" href="/z/d/graphic/128983.html" rel="external">
          picture 13
         </a>
         ). A skin biopsy is not usually necessary but may also detect
         <em>
          Demodex
         </em>
         mites. (See
         <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">
          "Office-based dermatologic diagnostic procedures", section on 'Potassium hydroxide preparation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Clinical correlation is necessary for the interpretation of the KOH preparation and skin biopsy findings because
         <em>
          Demodex
         </em>
         mites can be detected in normal skin, and a definitive threshold for diagnosis has not been established. In general, the KOH preparation may be considered positive when more than a few mites are detected [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although not typically performed in clinical practice, more than five mites per cm
         <sup>
          2
         </sup>
         detected on an adhesive skin-surface biopsy utilizing a cyanoacrylic adhesive has been proposed as a threshold for use in clinical studies [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Although not routinely used for diagnosis of folliculitis, the findings of an observational study suggest dermoscopy may be a helpful, adjunctive, diagnostic tool for some forms of folliculitis [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13521.html" rel="external">
          "Overview of dermoscopy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H604478874">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of infectious folliculitis includes the various forms of infectious folliculitis (eg, bacterial, fungal, viral,
         <em>
          Demodex
         </em>
         ) and other papular, pustular, or follicular eruptions.
        </p>
        <p>
         Common eruptions on the face or scalp that may be confused with infectious folliculitis include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acne vulgaris
         </strong>
         – The characteristic clinical features of acne vulgaris are open and closed comedones and inflammatory papules and pustules on the face, chest, shoulders, or back  (
         <a class="graphic graphic_picture graphicRef98492 graphicRef70809" href="/z/d/graphic/98492.html" rel="external">
          picture 14A-B
         </a>
         ). The presence of comedones and a lack of pruritus are more consistent with acne vulgaris than folliculitis. (See
         <a class="medical medical_review" href="/z/d/html/39.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Papulopustular rosacea
         </strong>
         – Papulopustular rosacea primarily affects adults and presents with pustules and erythematous papules on the central face  (
         <a class="graphic graphic_picture graphicRef67890 graphicRef63008" href="/z/d/graphic/67890.html" rel="external">
          picture 15A-B
         </a>
         ). Exacerbating factors, such as alcohol, spicy foods, sun exposure, and temperature changes, are common. (See
         <a class="medical medical_review" href="/z/d/html/13621.html" rel="external">
          "Rosacea: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perioral (periorificial) dermatitis
         </strong>
         – Perioral dermatitis presents with small, erythematous papules around the mouth, nose, or periorbital areas  (
         <a class="graphic graphic_picture graphicRef64577 graphicRef120219" href="/z/d/graphic/64577.html" rel="external">
          picture 16A-B
         </a>
         ). There may be associated mild scale. Perioral dermatitis is most common in young women. (See
         <a class="medical medical_review" href="/z/d/html/13622.html" rel="external">
          "Perioral (periorificial) dermatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acne keloidalis nuchae
         </strong>
         – Acne keloidalis nuchae is a chronic, scarring folliculitis that primarily affects males of African descent. Papules, pustules, and keloid-like papules and plaques develop on the posterior scalp  (
         <a class="graphic graphic_picture graphicRef97993" href="/z/d/graphic/97993.html" rel="external">
          picture 17
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15684.html" rel="external">
          "Acne keloidalis nuchae: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pseudofolliculitis barbae
         </strong>
         – Pseudofolliculitis barbae is an inflammatory reaction to hair penetrating interfollicular skin. Patients develop inflamed papules and pustules following hair removal in the beard area of the face or neck  (
         <a class="graphic graphic_picture graphicRef69365" href="/z/d/graphic/69365.html" rel="external">
          picture 18
         </a>
         ). Pseudofolliculitis barbae is most common in patients of African descent. (See
         <a class="medical medical_review" href="/z/d/html/3323.html" rel="external">
          "Pseudofolliculitis barbae"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Common eruptions in the differential diagnosis that most frequently affect the trunk or extremities include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Drug-induced folliculitis
         </strong>
         – A monomorphic, papulopustular eruption on the trunk and arms known as "steroid folliculitis" or "steroid acne" may occur after administration of systemic glucocorticoids  (
         <a class="graphic graphic_picture graphicRef86994 graphicRef86995" href="/z/d/graphic/86994.html" rel="external">
          picture 19A-B
         </a>
         ) [
         <a href="#rid30">
          30
         </a>
         ]. Other drugs that may cause folliculitis-like eruptions include
         <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">
          phenytoin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">
          lithium
         </a>
         ,
         <a class="drug drug_general" data-topicid="8577" href="/z/d/drug information/8577.html" rel="external">
          isoniazid
         </a>
         ,
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         , halogens, and epidermal growth factor receptor inhibitors  (
         <a class="graphic graphic_picture graphicRef55753" href="/z/d/graphic/55753.html" rel="external">
          picture 20
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15764.html" rel="external">
          "Acneiform eruption secondary to epidermal growth factor receptor (EGFR) and MEK inhibitors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/39.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Acneiform eruptions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Keratosis pilaris
         </strong>
         – Keratosis pilaris is a common disorder of follicular keratinization that presents with asymptomatic, keratotic, follicular papules on the upper arms, face, thighs, and buttocks  (
         <a class="graphic graphic_picture graphicRef68488 graphicRef60786" href="/z/d/graphic/68488.html" rel="external">
          picture 21A-B
         </a>
         ). Keratosis pilaris is most commonly seen in children and young adults. (See
         <a class="medical medical_review" href="/z/d/html/13663.html" rel="external">
          "Keratosis pilaris"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hidradenitis suppurativa
         </strong>
         – Hidradenitis suppurativa is a chronic, inflammatory skin disorder characterized by the development of inflamed nodules, abscesses, and sinus tracts  (
         <a class="graphic graphic_picture graphicRef90465" href="/z/d/graphic/90465.html" rel="external">
          picture 22
         </a>
         ). Involvement primarily occurs in the axillary, mammary, and inguinal areas. (See
         <a class="medical medical_review" href="/z/d/html/5575.html" rel="external">
          "Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Scabies
         </strong>
         –
         <em>
          Sarcoptes scabiei
         </em>
         infestation often presents with intensely pruritic pustules and papules in the axillae, inguinal areas, interdigital web spaces, waistline, and volar wrists  (
         <a class="graphic graphic_picture graphicRef75169" href="/z/d/graphic/75169.html" rel="external">
          picture 23
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4038.html" rel="external">
          "Scabies: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Grover's disease (transient acantholytic dermatosis)
         </strong>
         – Grover's disease most commonly presents as erythematous papules on the chest and back in men in their fifth decade or older  (
         <a class="graphic graphic_picture graphicRef76504" href="/z/d/graphic/76504.html" rel="external">
          picture 24
         </a>
         ). Histopathology demonstrates focal, acantholytic dyskeratosis that is not centered upon hair follicles. (See
         <a class="medical medical_review" href="/z/d/html/5566.html" rel="external">
          "Grover's disease (transient and persistent acantholytic dermatosis)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Other disorders in the differential diagnosis include irritant folliculitis, actinic folliculitis, eosinophilic folliculitis, and perforating folliculitis. (See
         <a class="medical medical_review" href="/z/d/html/108935.html" rel="external">
          "Perforating dermatoses", section on 'Perforating folliculitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H313616456">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The etiology of folliculitis determines the best approach to treatment. (See
         <a class="local">
          'Bacterial folliculitis'
         </a>
         below and
         <a class="local">
          'Fungal folliculitis'
         </a>
         below and
         <a class="local">
          'Viral folliculitis'
         </a>
         below and
         <a class="local">
          'Demodex folliculitis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3304783491">
         <span class="h2">
          Bacterial folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The therapeutic approach to staphylococcal folliculitis, pseudomonal folliculitis, and other forms of gram-negative folliculitis differ. (See
         <a class="local">
          'Staphylococcal folliculitis'
         </a>
         below and
         <a class="local">
          'Pseudomonal folliculitis'
         </a>
         below and
         <a class="local">
          'Other gram-negative folliculitis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H19981424">
         <span class="h3">
          Staphylococcal folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because
         <em>
          S. aureus
         </em>
         folliculitis is the most common form of infectious folliculitis, patients with findings suggestive of this diagnosis are often assumed to have
         <em>
          S. aureus
         </em>
         infection and managed accordingly. Reassessment of the diagnosis is indicated when patients fail to respond to treatment (see
         <a class="local">
          'Diagnosis'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General approach to treatment
         </strong>
         – Treatment of staphylococcal folliculitis is not always necessary; mild folliculitis with few pustules often resolves spontaneously. In this scenario, we often suggest daily washing of the affected area with an antimicrobial cleanser, such as
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         , in an attempt to accelerate improvement; however, the efficacy of this approach has not been confirmed in clinical trials.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Typical indications for antibiotic treatment include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Extensive disease (numerous papules or pustules or with involvement of more than one body area)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent disease (folliculitis that does not resolve spontaneously within several weeks)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Treatment with a topical antistaphylococcal antibiotic is usually sufficient for patients with limited skin involvement based upon clinical experience [
         <a href="#rid38">
          38
         </a>
         ]. We typically treat with topical
         <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">
          mupirocin
         </a>
         three times daily for five to seven days or topical
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         gel, lotion, or solution twice daily for 7 to 10 days.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other treatment options include topical
         <a class="drug drug_general" data-topicid="10271" href="/z/d/drug information/10271.html" rel="external">
          retapamulin
         </a>
         and topical
         <a class="drug drug_general" data-topicid="8648" href="/z/d/drug information/8648.html" rel="external">
          fusidic acid
         </a>
         [
         <a href="#rid39">
          39
         </a>
         ]. However, increasing resistance of
         <em>
          S. aureus
         </em>
         to fusidic acid has been observed in areas where fusidic acid use is common, and the drug is not available in the United States [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Topical
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         has fallen out of favor due to increasing prevalence of erythromycin resistance and community-acquired methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) infections [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Extensive, recurrent, or refractory folliculitis and folliculitis (sycosis) barbae
         </strong>
         – Patients with extensive skin involvement, staphylococcal folliculitis that is recurrent or refractory after topical therapy, or folliculitis barbae are usually treated with oral antibiotics. A 7- to 10-day course is usually sufficient.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In our experience, staphylococcal folliculitis, particularly of the scalp or trunk, is sometimes persistent or recurrent despite treatment. There are insufficient data to confirm the best approach to refractory staphylococcal folliculitis. In clinical practice, these patients are often given extended courses of oral antibiotics (eg, one month or longer). Selection of the antibiotic should be based upon culture and antibiotic sensitivity results. We often use
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         in this scenario. Measures to prevent recurrences may also be implemented.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Due to the high frequency of resistance to penicillin, other beta-lactam antibiotics, such as
         <a class="drug drug_general" data-topicid="9349" href="/z/d/drug information/9349.html" rel="external">
          dicloxacillin
         </a>
         or
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          cephalexin
         </a>
         , are first-line systemic treatments when MRSA infection is not suspected [
         <a href="#rid4">
          4,41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/473.html" rel="external">
          "Penicillin, antistaphylococcal penicillins, and broad-spectrum penicillins"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Typical adult dosing is as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9349" href="/z/d/drug information/9349.html" rel="external">
          Dicloxacillin
         </a>
         (250 to 500 mg four times per day)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          Cephalexin
         </a>
         (250 to 500 mg four times per day)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If MRSA is cultured or suspected  (
         <a class="graphic graphic_table graphicRef53504" href="/z/d/graphic/53504.html" rel="external">
          table 1
         </a>
         ), suggested treatments for adults include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          Doxycycline
         </a>
         (100 mg twice daily)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          Trimethoprim-sulfamethoxazole
         </a>
         (one to two double-strength tablets twice daily)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          Clindamycin
         </a>
         (450 mg three times per day)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Occasionally, treatment for more than two weeks is required for resolution of MRSA folliculitis [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3176.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention
         </strong>
         – The best approach to the prevention of recurrence is unclear. Reduction of predisposing factors for folliculitis (eg, occlusive clothing, hyperhidrosis) may be beneficial. In our experience, wearing loose-fitting clothing, particularly during exercise, and changing shirts after activities with excessive sweating seem to be helpful. We often also advise daily use of an antimicrobial cleanser, such as a cleanser containing
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         or a stabilized hypochlorous acid wash; however, the efficacy of this approach is unclear.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Decolonization regimens have been suggested for patients with recurrent abscesses in an attempt to reduce recurrences [
         <a href="#rid42">
          42
         </a>
         ]. However, data are insufficient to confirm efficacy of such measures for recurrent staphylococcal folliculitis. We generally limit decolonization to patients with recurrent MRSA skin infections. Decolonization regimens are reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4048.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control", section on 'Decolonization'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6025.html" rel="external">
          "Methicillin-resistant
          <i>
           Staphylococcus aureus
          </i>
          (MRSA) in children: Prevention and control", section on 'Decolonization regimens'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19981454">
         <span class="h3">
          Pseudomonal folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gram-negative folliculitis due to
         <em>
          Pseudomonas
         </em>
         is often self-limiting and resolves within 7 to 10 days with just good skin hygiene and avoidance of re-exposure to the source of infection (ie, contaminated water). Thus, treatment is not necessary for most patients.
        </p>
        <p>
         Patients with severe presentations (extensive skin involvement or disabling pruritus) may be treated with oral
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         (adult dose: 250 to 750 mg twice daily) [
         <a href="#rid3">
          3
         </a>
         ]. Data are insufficient to determine the optimal treatment duration; we consider a seven-day treatment course reasonable.
        </p>
        <p>
         Proper chlorination of pools and hot tubs prevents reinfection.
        </p>
        <p class="headingAnchor" id="H1194647442">
         <span class="h3">
          Other gram-negative folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Selection of an antibiotic for other forms of gram-negative folliculitis should be guided by antibacterial susceptibility testing of the causative organism. (See
         <a class="medical medical_review" href="/z/d/html/467.html" rel="external">
          "Overview of antibacterial susceptibility testing"
         </a>
         .)
        </p>
        <p>
         Common first-line treatment regimens for adults include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          Ampicillin
         </a>
         (250 to 500 mg four times daily)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          Trimethoprim-sulfamethoxazole
         </a>
         (one double-strength tablet twice daily)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          Ciprofloxacin
         </a>
         (250 to 750 mg twice daily)
        </p>
        <p>
        </p>
        <p>
         Treatment for two weeks is usually sufficient, although longer courses may be appropriate for patients who have incomplete clearance at the end of this period.
        </p>
        <p>
         Oral
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         (0.5 to 1 mg/kg daily for four to five months) is the treatment of choice for recalcitrant disease [
         <a href="#rid10">
          10,43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/38.html" rel="external">
          "Oral isotretinoin therapy for acne vulgaris"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4094567817">
         <span class="h2">
          Fungal folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The approach to the treatment of fungal folliculitis depends on the etiology. Oral antifungal agents such as
         <a class="drug drug_general" data-topicid="9677" href="/z/d/drug information/9677.html" rel="external">
          terbinafine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          fluconazole
         </a>
         , and
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         are common treatments.
        </p>
        <p>
         Oral
         <a class="drug drug_general" data-topicid="8589" href="/z/d/drug information/8589.html" rel="external">
          ketoconazole
         </a>
         should
         <strong>
          not
         </strong>
         be used for the treatment of any form of fungal folliculitis due to risks of liver injury, adrenal gland disorders, and significant drug interactions [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H864477576">
         <span class="h3">
          <i>
           Malassezia
          </i>
          folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment options for
         <em>
          Malassezia
         </em>
         folliculitis include both oral antifungal drugs (eg,
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          fluconazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         ) and topical antifungal drugs (eg, azole antifungal drugs,
         <a class="drug drug_general" data-topicid="9885" href="/z/d/drug information/9885.html" rel="external">
          selenium sulfide
         </a>
         ). The efficacy of
         <a class="drug drug_general" data-topicid="9677" href="/z/d/drug information/9677.html" rel="external">
          terbinafine
         </a>
         for this indication is unclear:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General approach
         </strong>
         – Oral therapy is often considered more effective than topical therapy based upon the theory that systemic therapy may eliminate
         <em>
          Malassezia
         </em>
         deep within hair follicles [
         <a href="#rid44">
          44
         </a>
         ]. However, superiority of systemic therapy is not confirmed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The best regimens for treatment are unclear. Examples of reasonable systemic approaches include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Oral
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          fluconazole
         </a>
         (100 to 200 mg per day for one to four weeks or 300 mg once weekly for one to two months [
         <a href="#rid44">
          44
         </a>
         ])
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Oral
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         (200 mg per day for one to three weeks [
         <a href="#rid44">
          44
         </a>
         ])
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We usually treat with oral
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          fluconazole
         </a>
         based upon the drug's more favorable side effect profile and lower risk for drug interactions compared with
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Examples of reasonable topical regimens include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="8589" href="/z/d/drug information/8589.html" rel="external">
          Ketoconazole
         </a>
         shampoo applied for five minutes three to four times per week for approximately one month
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Topical azole antifungal agent (eg,
         <a class="drug drug_general" data-topicid="8589" href="/z/d/drug information/8589.html" rel="external">
          ketoconazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="9287" href="/z/d/drug information/9287.html" rel="external">
          clotrimazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="9400" href="/z/d/drug information/9400.html" rel="external">
          econazole
         </a>
         ) applied once or twice daily for approximately one month  (
         <a class="graphic graphic_table graphicRef76148" href="/z/d/graphic/76148.html" rel="external">
          table 2
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Large, high-quality studies evaluating the efficacy of treatments are lacking. One small, randomized trial (n = 26) found oral
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         (200 mg per day for one week) superior to placebo (clinical clearance in 69 versus 0 percent and negative potassium hydroxide [KOH] preparation in 85 versus 8 percent after five weeks) [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Uncontrolled and retrospective studies also support benefit of oral
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          fluconazole
         </a>
         and topical antifungal treatments, such as topical
         <a class="drug drug_general" data-topicid="8589" href="/z/d/drug information/8589.html" rel="external">
          ketoconazole
         </a>
         shampoo, ketoconazole cream,
         <a class="drug drug_general" data-topicid="9400" href="/z/d/drug information/9400.html" rel="external">
          econazole
         </a>
         cream,
         <a class="drug drug_general" data-topicid="9885" href="/z/d/drug information/9885.html" rel="external">
          selenium sulfide
         </a>
         shampoo, and propylene glycol 50% in water, for achieving improvement or resolution. [
         <a href="#rid13">
          13,17,46
         </a>
         ]. In contrast, poor efficacy of topical azole antifungal drug monotherapy was reported in a study that compared outcomes from treatment with oral ketoconazole (alone or in conjunction with ketoconazole shampoo), econazole nitrate 1% solution, and
         <a class="drug drug_general" data-topicid="16763" href="/z/d/drug information/16763.html" rel="external">
          miconazole
         </a>
         nitrate 1% cream in 62 patients with
         <em>
          Malassezia
         </em>
         folliculitis [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention of recurrence
         </strong>
         – Recurrence is common after treatment. Long-term, periodic (eg, once- or twice-weekly) use of topical treatments, often
         <a class="drug drug_general" data-topicid="9885" href="/z/d/drug information/9885.html" rel="external">
          selenium sulfide
         </a>
         ,
         <a class="drug drug_general" data-topicid="8589" href="/z/d/drug information/8589.html" rel="external">
          ketoconazole
         </a>
         , or
         <a class="drug drug_general" data-topicid="9263" href="/z/d/drug information/9263.html" rel="external">
          ciclopirox
         </a>
         shampoos, is performed in an attempt to prevent recurrence of disease [
         <a href="#rid37">
          37,47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other interventions
         </strong>
         – Although not typically indicated, improvement of
         <em>
          Malassezia
         </em>
         folliculitis with
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         or photodynamic therapy has been reported [
         <a href="#rid44">
          44,48,49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1201667224">
         <span class="h3">
          Dermatophytic folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dermatophytic folliculitis must be treated with systemic therapy. Topical antifungals may help to reduce transmission of infection but are usually ineffective for treatment due to insufficient penetration of the hair follicle:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tinea barbae and Majocchi's granuloma
         </strong>
         – Oral
         <a class="drug drug_general" data-topicid="9677" href="/z/d/drug information/9677.html" rel="external">
          terbinafine
         </a>
         is our preferred first-line treatment of tinea barbae and Majocchi's granuloma. We typically treat adults with oral terbinafine (250 mg per day) for four weeks, with the precise duration of treatment determined based upon clinical response. Treatment is continued until complete clinical resolution. Case reports and case series describe resolution of disease with doses ranging from 250 to 500 mg of terbinafine per day for four to six weeks or longer [
         <a href="#rid18">
          18,50-53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Oral
         <a class="drug drug_general" data-topicid="8502" href="/z/d/drug information/8502.html" rel="external">
          griseofulvin
         </a>
         and
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         are also considered effective for dermatophytic folliculitis and are alternatives to
         <a class="drug drug_general" data-topicid="9677" href="/z/d/drug information/9677.html" rel="external">
          terbinafine
         </a>
         [
         <a href="#rid3">
          3,18,54,55
         </a>
         ]. A case series of seven successfully treated patients with Majocchi's granuloma suggests efficacy of pulse therapy with itraconazole (up to three pulses of 200 mg twice daily for one week followed by two weeks off therapy) [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Our typical regimen for
         <a class="drug drug_general" data-topicid="8502" href="/z/d/drug information/8502.html" rel="external">
          griseofulvin
         </a>
         therapy for adults treated is 500 mg daily (microsize) for four to eight weeks. Our preferred regimen for
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         is 200 mg twice daily for one week per month for one to three months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tinea capitis
         </strong>
         – The management of tinea capitis is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/99983.html" rel="external">
          "Tinea capitis", section on 'Treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2809574015">
         <span class="h3">
          Candida folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Candida
         </em>
         folliculitis can be treated with oral
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          fluconazole
         </a>
         or
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         . Oral
         <a class="drug drug_general" data-topicid="9677" href="/z/d/drug information/9677.html" rel="external">
          terbinafine
         </a>
         is not effective [
         <a href="#rid3">
          3,21
         </a>
         ]. Our typical approach for localized
         <em>
          Candida
         </em>
         folliculitis is to give fluconazole 150 mg per
         <strong>
          week
         </strong>
         for two to four weeks or fluconazole 50 mg per day for four weeks.
        </p>
        <p>
         However, data on the treatment of localized
         <em>
          Candida
         </em>
         folliculitis are limited and insufficient to determine the most appropriate approach to treatment. Examples of regimens that have been associated with improvement in case reports or small case series include
         <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">
          fluconazole
         </a>
         100 mg per day for one week followed by every other day for one month, fluconazole 50 mg per day for four weeks, and
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         200 mg per day for two weeks [
         <a href="#rid20">
          20,21,56
         </a>
         ].
        </p>
        <p>
         Patients with associated candidemia should be treated accordingly. (See
         <a class="medical medical_review" href="/z/d/html/2430.html" rel="external">
          "Management of candidemia and invasive candidiasis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6014.html" rel="external">
          "Candidemia and invasive candidiasis in children: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3935842658">
         <span class="h2">
          Viral folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The therapeutic approaches for herpetic folliculitis and molluscum folliculitis differ.
        </p>
        <p class="headingAnchor" id="H2802482198">
         <span class="h3">
          Herpetic folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Herpetic folliculitis should be treated with systemic antiviral therapy.
        </p>
        <p>
         Data on treatments for herpes folliculitis are limited, and the most appropriate regimens for antiviral therapy for herpetic folliculitis are unclear. Various dose regimens have been utilized [
         <a href="#rid25">
          25,26,57,58
         </a>
         ]. We consider doses resembling those used for herpes zoster reasonable, particularly in the setting of herpes folliculitis secondary to varicella zoster virus (VZV) infection:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9335" href="/z/d/drug information/9335.html" rel="external">
          Acyclovir
         </a>
         – 800 mg five times per day for seven days
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="10034" href="/z/d/drug information/10034.html" rel="external">
          Valacyclovir
         </a>
         – 1 g three times daily for seven days
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8435" href="/z/d/drug information/8435.html" rel="external">
          Famciclovir
         </a>
         – 500 mg three times per day for seven days
        </p>
        <p>
        </p>
        <p>
         Case reports suggest lower doses or shorter courses may be effective in patients with herpes simplex virus (HSV)-related herpetic folliculitis [
         <a href="#rid25">
          25,26,58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8287.html" rel="external">
          "Treatment and prevention of herpes simplex virus type 1 in immunocompetent adolescents and adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2858599875">
         <span class="h3">
          Molluscum folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Molluscum folliculitis can be treated similarly to classic molluscum contagiosum infection. Common treatment options for molluscum contagiosum include curettage,
         <a class="drug drug_general" data-topicid="8838" href="/z/d/drug information/8838.html" rel="external">
          cantharidin
         </a>
         , and cryotherapy.
         <a class="drug drug_general" data-topicid="10218" href="/z/d/drug information/10218.html" rel="external">
          Podophyllotoxin
         </a>
         and
         <a class="drug drug_general" data-topicid="10296" href="/z/d/drug information/10296.html" rel="external">
          trichloroacetic acid
         </a>
         are additional treatments [
         <a href="#rid3">
          3
         </a>
         ]. We typically treat with cantharidin or cryotherapy. (See
         <a class="medical medical_review" href="/z/d/html/4033.html" rel="external">
          "Molluscum contagiosum", section on 'Overview of management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1102844384">
         <span class="h2">
          <i>
           Demodex
          </i>
          folliculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data on treatment options for
         <em>
          Demodex
         </em>
         folliculitis are limited. We typically treat with
         <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">
          permethrin
         </a>
         5% cream or oral
         <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">
          ivermectin
         </a>
         . Additional treatment options include topical sulfur and oral
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         Topical
         <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">
          permethrin
         </a>
         can be applied to the entire face before bed and washed off after 8 to 14 hours. Oral
         <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">
          ivermectin
         </a>
         can be given as two 200 mcg/kg doses separated by one week.
        </p>
        <p>
         The findings of one randomized trial suggest that combination therapy with oral
         <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">
          ivermectin
         </a>
         and oral
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         is more effective for reducing mite counts than oral ivermectin monotherapy [
         <a href="#rid31">
          31
         </a>
         ]; however, further study is necessary to confirm whether combination therapy is indicated for
         <em>
          Demodex
         </em>
         folliculitis. The efficacy of topical ivermectin remains to be determined.
        </p>
        <p class="headingAnchor" id="H1230511060">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110086.html" rel="external">
          "Society guideline links: Skin and soft tissue infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2053577706">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/17202.html" rel="external">
          "Patient education: Bacterial folliculitis (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H604478994">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology
         </strong>
         – Folliculitis is inflammation of the superficial or deep portion of the hair follicle. Folliculitis may be infectious or noninfectious. Infectious folliculitis can be caused by bacteria, fungi, viruses, or parasites. The most common pathogen in infectious folliculitis is
         <em>
          Staphylococcus aureus
         </em>
         .
         <em>
         </em>
         Other common pathogens are
         <em>
          Pseudomonas aeruginosa
         </em>
         ,
         <em>
          Malassezia
         </em>
         species, and
         <em>
          Demodex
         </em>
         mites. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – Follicular pustules and follicular, erythematous papules are the most common clinical findings of folliculitis. (See
         <a class="local">
          'Bacterial folliculitis'
         </a>
         above and
         <a class="local">
          'Fungal folliculitis'
         </a>
         above and
         <a class="local">
          'Viral folliculitis'
         </a>
         above and
         <a class="local">
          'Demodex folliculitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – A diagnosis of folliculitis can often be made based upon the patient history and clinical findings. Further testing is necessary when the etiology is unclear. A Gram stain, bacterial culture, potassium hydroxide (KOH) preparation, viral culture, polymerase chain reaction (PCR) assay, or immunofluorescence testing can aid in diagnosis, depending on the type of folliculitis suspected. Skin biopsies are not usually necessary but may be helpful in difficult cases. (See
         <a class="local">
          'Bacterial folliculitis'
         </a>
         above and
         <a class="local">
          'Fungal folliculitis'
         </a>
         above and
         <a class="local">
          'Viral folliculitis'
         </a>
         above and
         <a class="local">
          'Demodex folliculitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – The management of folliculitis varies based upon the etiology:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mild staphylococcal folliculitis
         </strong>
         – Mild
         <em>
          S. aureus
         </em>
         folliculitis may resolve without antibiotic treatment. For patients with known or suspected
         <em>
          S. aureus
         </em>
         folliculitis that persists and involves a limited area of skin, we suggest topical antibiotic therapy rather than oral antibiotic therapy as initial treatment (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Topical
         <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">
          mupirocin
         </a>
         and topical
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         are our preferred initial treatments. (See
         <a class="local">
          'Staphylococcal folliculitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Extensive staphylococcal folliculitis
         </strong>
         – For patients with extensive
         <em>
          S. aureus
         </em>
         folliculitis,
         <em>
          S. aureus
         </em>
         folliculitis that fails to resolve or recurs after topical treatment, or folliculitis barbae, we suggest systemic antibiotic therapy rather than topical antibiotic therapy (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Appropriate initial treatment options include
         <a class="drug drug_general" data-topicid="9349" href="/z/d/drug information/9349.html" rel="external">
          dicloxacillin
         </a>
         and
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          cephalexin
         </a>
         . If methicillin-resista
         <em>
          nt Staphylococcus aureus
         </em>
         (MRSA) is suspected, patients should be treated with
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         , or
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         . (See
         <a class="local">
          'Staphylococcal folliculitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other types of folliculitis
         </strong>
         – Oral antifungal therapy is the mainstay of therapy for fungal folliculitis. Antiparasitic agents, such as
         <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">
          permethrin
         </a>
         and oral
         <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">
          ivermectin
         </a>
         , can be effective for
         <em>
          Demodex
         </em>
         folliculitis. (See
         <a class="local">
          'Fungal folliculitis'
         </a>
         above and
         <a class="local">
          'Demodex folliculitis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol 2007; 8:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Natsis NE, Cohen PR. Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections. Am J Clin Dermatol 2018; 19:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol 2004; 5:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laureano AC, Schwartz RA, Cohen PJ. Facial bacterial infections: folliculitis. Clin Dermatol 2014; 32:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu Y, Cheng AS, Wang L, et al. Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa. J Am Acad Dermatol 2007; 57:596.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teraki Y, Nakamura K. Rubbing skin with nylon towels as a major cause of pseudomonas folliculitis in a Japanese population. J Dermatol 2015; 42:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazza J, Borkin M, Buchholz R, Deleo V. Pseudomonas folliculitis contracted from rubber gloves: a public health concern. J Am Acad Dermatol 2013; 69:e93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kitamura M, Kawai S, Horio T. Pseudomonas aeruginosa folliculitis: a sporadic case from use of a contaminated sponge. Br J Dermatol 1998; 139:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Julià Manresa M, Vicente Villa A, Gené Giralt A, González-Enseñat MA. Aeromonas hydrophila folliculitis associated with an inflatable swimming pool: mimicking Pseudomonas aeruginosa infection. Pediatr Dermatol 2009; 26:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neubert U, Jansen T, Plewig G. Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients. Int J Dermatol 1999; 38:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durdu M, Güran M, Ilkit M. Epidemiological characteristics of Malassezia folliculitis and use of the May-Grünwald-Giemsa stain to diagnose the infection. Diagn Microbiol Infect Dis 2013; 76:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pedrosa AF, Lisboa C, Gonçalves Rodrigues A. Malassezia infections: a medical conundrum. J Am Acad Dermatol 2014; 71:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suzuki C, Hase M, Shimoyama H, Sei Y. Treatment Outcomes for Malassezia Folliculitis in theDermatology Department of a University Hospital in Japan. Med Mycol J 2016; 57:E63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubenstein RM, Malerich SA. Malassezia (pityrosporum) folliculitis. J Clin Aesthet Dermatol 2014; 7:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaitanis G, Velegraki A, Mayser P, Bassukas ID. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin Dermatol 2013; 31:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant 2000; 19:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: A retrospective review of 110 cases. J Am Acad Dermatol 2018; 78:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ilkit M, Durdu M, Karakaş M. Majocchi's granuloma: a symptom complex caused by fungal pathogens. Med Mycol 2012; 50:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansur AT, Aydingoz IE, Artunkal S. Facial Candida folliculitis: possible role of sexual contact. Mycoses 2012; 55:e20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durdu M, Güran M, Kandemir H, et al. Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies. Mycopathologia 2016; 181:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapdağli H, Oztürk G, Dereli T, et al. Candida folliculitis mimicking tinea barbae. Int J Dermatol 1997; 36:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oon HH, Lim KS, Chong WS, Tan SH. Erythematous and edematous eruption of the face. Herpes folliculitis. Int J Dermatol 2010; 49:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Böer A, Herder N, Winter K, Falk T. Herpes folliculitis: clinical, histopathological, and molecular pathologic observations. Br J Dermatol 2006; 154:743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campanelli A, Marazza G, Stucki L, et al. Fulminant herpetic sycosis: atypical presentation of primary herpetic infection. Dermatology 2004; 208:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Dhafiri SA, Molinari R. Herpetic folliculitis. J Cutan Med Surg 2002; 6:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jang KA, Kim SH, Choi JH, et al. Viral folliculitis on the face. Br J Dermatol 2000; 142:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feldmeyer L, Kamarashev J, Boehler A, et al. Molluscum contagiosum folliculitis mimicking tinea barbae in a lung transplant recipient. J Am Acad Dermatol 2010; 63:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee B, Kang HY. Molluscum folliculitis after leg shaving. J Am Acad Dermatol 2004; 51:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiu HH, Chen PH, Wu CS, et al. Paediatric molluscum folliculitis: a diagnosis to keep in mind. J Eur Acad Dermatol Venereol 2009; 23:1108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dessinioti C, Antoniou C, Katsambas A. Acneiform eruptions. Clin Dermatol 2014; 32:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salem DA, El-Shazly A, Nabih N, et al. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis 2013; 17:e343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rusiecka-Ziółkowska J, Nokiel M, Fleischer M. Demodex - an old pathogen or a new one? Adv Clin Exp Med 2014; 23:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown M, Hernández-Martín A, Clement A, et al. Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin. JAMA Dermatol 2014; 150:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elston CA, Elston DM. Demodex mites. Clin Dermatol 2014; 32:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol 2014; 170:1219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forton F, Seys B, Marchal JL, Song AM. Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy. Br J Dermatol 1998; 138:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durdu M, Errichetti E, Eskiocak AH, Ilkit M. High accuracy of recognition of common forms of folliculitis by dermoscopy: An observational study. J Am Acad Dermatol 2019; 81:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lopez FA, Lartchenko S. Skin and soft tissue infections. Infect Dis Clin North Am 2006; 20:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bohaty BR, Choi S, Cai C, Hebert AA. Clinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections. Int J Womens Dermatol 2015; 1:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williamson DA, Monecke S, Heffernan H, et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. Clin Infect Dis 2014; 59:1451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Bijnen EM, Paget WJ, den Heijer CD, et al. Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. BMC Fam Pract 2014; 15:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Böni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol 2003; 4:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hald M, Arendrup MC, Svejgaard EL, et al. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. Acta Derm Venereol 2015; 95:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsad D, Saini R, Negi KS. Short-term treatment of pityrosporum folliculitis: a double blind placebo-controlled study. J Eur Acad Dermatol Venereol 1998; 11:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bäck O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol 1985; 12:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdel-Razek M, Fadaly G, Abdel-Raheim M, al-Morsy F. Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials. Clin Exp Dermatol 1995; 20:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JW, Lee HI, Kim MN, et al. Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis. Int J Dermatol 2011; 50:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JW, Kim BJ, Kim MN. Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis. Lasers Surg Med 2010; 42:192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonifaz A, Ramírez-Tamayo T, Saúl A. Tinea barbae (tinea sycosis): experience with nine cases. J Dermatol 2003; 30:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang X, Yang Y, Li R, Yu J. Two Cases of Dermatophytic Granuloma Successfully Treated with Terbinafine. Mycopathologia 2018; 183:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou S, Yang Y, Liu K, et al. A Case Report of Widespread Majocchi's Granuloma in a Patient with Systemic Lupus Erythematosus. Mycopathologia 2017; 182:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chou WY, Hsu CJ. A Case Report of Majocchi's Granuloma Associated with Combined Therapy of Topical Steroids and Adalimumab. Medicine (Baltimore) 2016; 95:e2245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta AK, Groen K, Woestenborghs R, De Doncker P. Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Clin Exp Dermatol 1998; 23:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feng WW, Chen HC, Chen HC. Majocchi's granuloma in a 3-year-old boy. Pediatr Infect Dis J 2006; 25:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kick G, Korting HC. Debilitating folliculitis barbae candidomycetica in a trumpeter: successful treatment with fluconazole. Mycoses 1998; 41:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brabek E, El Shabrawi-Caelen L, Woltsche-Kahr I, et al. Herpetic folliculitis and syringitis simulating acne excoriée. Arch Dermatol 2001; 137:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foti C, Filotico R, Calvario A, et al. Relapsing herpes simplex-2 folliculitis in the beard area. Eur J Dermatol 2004; 14:421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elston DM. Demodex mites: facts and controversies. Clin Dermatol 2010; 28:502.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 103297 Version 16.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17902728" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29882122" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15554731" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Folliculitis: recognition and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25441463" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Facial bacterial infections: folliculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17658195" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25423895" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Rubbing skin with nylon towels as a major cause of pseudomonas folliculitis in a Japanese population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23866894" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Pseudomonas folliculitis contracted from rubber gloves: a public health concern.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9767271" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Pseudomonas aeruginosa folliculitis: a sporadic case from use of a contaminated sponge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19840320" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Aeromonas hydrophila folliculitis associated with an inflatable swimming pool: mimicking Pseudomonas aeruginosa infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10321942" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23706503" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Epidemiological characteristics of Malassezia folliculitis and use of the May-Grünwald-Giemsa stain to diagnose the infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24569116" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Malassezia infections: a medical conundrum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27581777" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Treatment Outcomes for Malassezia Folliculitis in theDermatology Department of a University Hospital in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24688625" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Malassezia (pityrosporum) folliculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23806162" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Skin diseases associated with Malassezia yeasts: facts and controversies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10703699" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29138059" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Pityrosporum folliculitis: A retrospective review of 110 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22435879" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Majocchi's granuloma: a symptom complex caused by fungal pathogens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21777297" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Facial Candida folliculitis: possible role of sexual contact.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26337525" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9169333" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Candida folliculitis mimicking tinea barbae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20883259" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Erythematous and edematous eruption of the face. Herpes folliculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16536821" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Herpes folliculitis: clinical, histopathological, and molecular pathologic observations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15118392" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Fulminant herpetic sycosis: atypical presentation of primary herpetic infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11896419" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Herpetic folliculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10735972" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Viral folliculitis on the face.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20542185" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Molluscum contagiosum folliculitis mimicking tinea barbae in a lung transplant recipient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15338001" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Molluscum folliculitis after leg shaving.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19192014" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Paediatric molluscum folliculitis: a diagnosis to keep in mind.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24314375" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Acneiform eruptions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23294870" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24913122" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Demodex - an old pathogen or a new one?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24284904" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25441466" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Demodex mites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24471456" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Human demodicosis: revisit and a proposed classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9580800" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30914342" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : High accuracy of recognition of common forms of folliculitis by dermoscopy: An observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17118289" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Skin and soft tissue infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28491950" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Clinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25139961" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25413920" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24973422" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12680804" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Treatment of gram-negative folliculitis in patients with acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24556907" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9784054" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Short-term treatment of pityrosporum folliculitis: a double blind placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3980804" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Pityrosporum folliculitis: a common disease of the young and middle-aged.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8593718" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21413966" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20166153" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14739517" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Tinea barbae (tinea sycosis): experience with nine cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29344845" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Two Cases of Dermatophytic Granuloma Successfully Treated with Terbinafine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28083794" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A Case Report of Widespread Majocchi's Granuloma in a Patient with Systemic Lupus Erythematosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26765401" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : A Case Report of Majocchi's Granuloma Associated with Combined Therapy of Topical Steroids and Adalimumab.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9861736" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16804445" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Majocchi's granuloma in a 3-year-old boy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9861841" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Debilitating folliculitis barbae candidomycetica in a trumpeter: successful treatment with fluconazole.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11176676" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Herpetic folliculitis and syringitis simulating acne excoriée.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15564209" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Relapsing herpes simplex-2 folliculitis in the beard area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20797509" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Demodex mites: facts and controversies.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
